blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1438104

EP1438104 - CO-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.02.2007
Database last updated on 02.09.2024
Most recent event   Tooltip12.12.2008Lapse of the patent in a contracting state
New state(s): CY		published on 14.01.2009  [2009/03]
Applicant(s)For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine, CA 92612 / US
[N/P]
Former [2006/14]For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine, California 92612 / US
Former [2004/30]For all designated states
Allergan, Inc.
2525 Dupont Drive
Irvine, California 92612 / US
Inventor(s)01 / BURK, Robert, M.
1337 Cerritos Drive
Laguna Beach, CA 92651 / US
02 / HOLOBOSKI, Mark
29342 Bobolink Drive
Laguna Niguel, CA 92677 / US
03 / POSNER, Mari, F.
27935 Hedgeline Drive
Laguna Niguel, CA 92677 / US
 [2004/30]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
[N/P]
Former [2008/31]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Former [2004/30]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date01273246.726.10.2001
[2004/30]
WO2001US28609
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03037433
Date:08.05.2003
Language:EN
[2003/19]
Type: A1 Application with search report 
No.:EP1438104
Date:21.07.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 08.05.2003 takes the place of the publication of the European patent application.
[2004/30]
Type: B1 Patent specification 
No.:EP1438104
Date:05.04.2006
Language:EN
[2006/14]
Search report(s)International search report - published on:EP08.05.2003
ClassificationIPC:A61P27/06, C07D333/24, A61K31/559
[2004/30]
CPC:
C07D333/24 (EP); A61K31/559 (EP); A61P1/10 (EP);
A61P11/00 (EP); A61P11/06 (EP); A61P13/12 (EP);
A61P15/00 (EP); A61P15/10 (EP); A61P19/10 (EP);
A61P27/00 (EP); A61P27/06 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P37/02 (EP); A61P43/00 (EP);
A61P5/24 (EP); A61P7/02 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/10 (EP); A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/30]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:OMEGA-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGEN ALS EP2-REZEPTOR AGONISTEN[2004/30]
English:CO-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS[2004/30]
French:ANALOGUES E2 DE PROSTAGLANDINE CO-CYCLOALKYLE 17-HETEROARYLE UTILISES EN TANT QU'AGONISTES DU RECEPTEUR EP2[2004/30]
Entry into regional phase24.04.2003National basic fee paid 
24.04.2003Designation fee(s) paid 
24.04.2003Examination fee paid 
Examination procedure13.05.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
24.04.2003Amendment by applicant (claims and/or description)
24.04.2003Examination requested  [2004/30]
08.02.2005Despatch of a communication from the examining division (Time limit: M04)
20.06.2005Reply to a communication from the examining division
01.08.2005Communication of intention to grant the patent
15.11.2005Fee for grant paid
15.11.2005Fee for publishing/printing paid
Opposition(s)08.01.2007No opposition filed within time limit [2007/11]
Fees paidRenewal fee
23.10.2003Renewal fee patent year 03
25.10.2004Renewal fee patent year 04
27.10.2005Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT05.04.2006
BE05.04.2006
CH05.04.2006
CY05.04.2006
FI05.04.2006
LI05.04.2006
NL05.04.2006
TR05.04.2006
DK05.07.2006
SE05.07.2006
GR06.07.2006
PT05.09.2006
IE26.10.2006
LU26.10.2006
MC31.10.2006
[2009/03]
Former [2008/37]AT05.04.2006
BE05.04.2006
CH05.04.2006
FI05.04.2006
LI05.04.2006
NL05.04.2006
TR05.04.2006
DK05.07.2006
SE05.07.2006
GR06.07.2006
PT05.09.2006
IE26.10.2006
LU26.10.2006
MC31.10.2006
Former [2008/19]AT05.04.2006
BE05.04.2006
CH05.04.2006
FI05.04.2006
LI05.04.2006
NL05.04.2006
DK05.07.2006
SE05.07.2006
GR06.07.2006
PT05.09.2006
IE26.10.2006
MC31.10.2006
Former [2007/50]AT05.04.2006
BE05.04.2006
CH05.04.2006
FI05.04.2006
LI05.04.2006
NL05.04.2006
DK05.07.2006
SE05.07.2006
PT05.09.2006
IE26.10.2006
MC31.10.2006
Former [2007/48]AT05.04.2006
BE05.04.2006
CH05.04.2006
FI05.04.2006
IT05.04.2006
LI05.04.2006
NL05.04.2006
DK05.07.2006
SE05.07.2006
PT05.09.2006
IE26.10.2006
MC31.10.2006
Former [2007/37]AT05.04.2006
BE05.04.2006
CH05.04.2006
FI05.04.2006
IT05.04.2006
LI05.04.2006
NL05.04.2006
DK05.07.2006
SE05.07.2006
PT05.09.2006
MC31.10.2006
Former [2007/36]AT05.04.2006
BE05.04.2006
CH05.04.2006
FI05.04.2006
IT05.04.2006
LI05.04.2006
NL05.04.2006
DK05.07.2006
SE05.07.2006
PT05.09.2006
Former [2007/19]AT05.04.2006
BE05.04.2006
CH05.04.2006
FI05.04.2006
LI05.04.2006
NL05.04.2006
DK05.07.2006
SE05.07.2006
PT05.09.2006
Former [2007/13]AT05.04.2006
BE05.04.2006
CH05.04.2006
FI05.04.2006
LI05.04.2006
DK05.07.2006
SE05.07.2006
PT05.09.2006
Former [2007/09]AT05.04.2006
CH05.04.2006
FI05.04.2006
LI05.04.2006
DK05.07.2006
SE05.07.2006
PT05.09.2006
Former [2007/03]AT05.04.2006
CH05.04.2006
FI05.04.2006
LI05.04.2006
SE05.07.2006
Former [2006/52]AT05.04.2006
FI05.04.2006
SE05.07.2006
Former [2006/51]FI05.04.2006
SE05.07.2006
Former [2006/48]SE05.07.2006
Cited inInternational search[A]US6307092  (BURK ROBERT M [US], et al) [A] * column 22 - column 27 *;
 [A]US5034413  (CHAN MING F [US], et al) [A] * the whole document *;
 [A]EP0410786  (ALLERGAN INC [US]) [A] * the whole document *;
 [A]US5028624  (CHAN MING F [US], et al) [A] * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.